Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

Author: Namer M.   Soler-Michel P.   Turpin F.   Chinet-Charrot P.   de Gislain C.   Pouillart P.   Delozier T.   Luporsi E.   Etienne P.L.   Schraub S.   Eymard J.C.   Serin D.   Ganem G.   Calais G.   Maillart P.   Colin P.   Trillet-Lenoir V.   Prevost G.   Tigaud D.   Clavere P.   Marti P.   Romieu G.   Wendling J.L.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.37, Iss.9, 2001-06, pp. : 1132-1140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content